Evaluating the Role of the Guidewire in Peripheral Intravenous Access
Withdrawn before enrolling · Not applicable
Conditions studied: Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
In brief
This study is to demonstrate that the control ultralong intravenous catheter without the guide wire is equivalent to the experimental catheter with the guide wire. The hypothesis of this study is that the 6.35 cm 20G ultralong Ultrasound Guided Peripheral Intravenous (USPIV) will have no difference in survival compared to the 5.71 cm ultralong with wire USPIV.
Key facts
- Study ID
- NCT04949854
- Run by
- Corewell Health East
- People needed
- 0
- Starts
- 2023-12-01
- Expected to finish
- 2023-12-01
- Last updated by the study team
- 2023-09-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Beaumont Hospitals — Royal Oak, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.